WILMINGTON, Mass., March 26, 2015 /PRNewswire/ — Implant Sciences Corporation (IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported the shipment of approximately $500,000 in explosives trace detection systems in Latin America, most of which were sold to a major international airline in Latin America.
“Implant Sciences continues to expand its market share in the Latin American aviation security space. We believe that the combination of our superior performance and value proposition is the impetus behind this success, which could also set the stage for follow-on orders from these customers,” stated Dr. Darryl Jones, Implant Sciences’ Global Vice President of Sales and Marketing. “We are seeing a significant increase in demand for our products since our recent checkpoint certifications from the US Transportation Security Administration (TSA) and the European Civil Aviation Conference (ECAC).”
“Our QS-B220 is specifically designed to meet the needs of aviation-related applications, including passenger, baggage, and cargo screening. As the only non-radioactive ETD in the world to pass the latest testing protocols of both TSA and ECAC, the QS-B220 is becoming the ETD of choice for a larger number of purchasers in the aviation security market,” added Dr. Bill McGann, CEO of Implant Sciences.
